Thrivent Financial for Lutherans Raises Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Thrivent Financial for Lutherans lifted its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 1,848.9% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 105,415 shares of the company's stock after buying an additional 100,006 shares during the quarter. Thrivent Financial for Lutherans owned about 0.08% of Henry Schein worth $7,685,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Natixis Advisors LLC raised its position in shares of Henry Schein by 18.8% during the 3rd quarter. Natixis Advisors LLC now owns 81,877 shares of the company's stock valued at $5,969,000 after purchasing an additional 12,930 shares during the period. Simplify Asset Management Inc. lifted its position in shares of Henry Schein by 61.6% in the third quarter. Simplify Asset Management Inc. now owns 5,972 shares of the company's stock valued at $435,000 after acquiring an additional 2,277 shares in the last quarter. CIBC Asset Management Inc boosted its stake in shares of Henry Schein by 7.0% in the third quarter. CIBC Asset Management Inc now owns 17,680 shares of the company's stock worth $1,289,000 after acquiring an additional 1,162 shares during the period. ING Groep NV bought a new stake in Henry Schein during the 3rd quarter valued at approximately $63,226,000. Finally, Tokio Marine Asset Management Co. Ltd. purchased a new position in Henry Schein in the 3rd quarter worth approximately $301,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company's stock, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Trading Up 1.8 %

Shares of HSIC stock traded up $1.31 during trading hours on Friday, reaching $75.08. 3,384,464 shares of the stock were exchanged, compared to its average volume of 1,902,142. The firm has a market capitalization of $9.36 billion, a price-to-earnings ratio of 30.90, a price-to-earnings-growth ratio of 2.12 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The company's 50-day moving average price is $70.89 and its 200-day moving average price is $69.76. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the prior year, the firm posted $1.32 earnings per share. The company's quarterly revenue was up .4% on a year-over-year basis. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Analyst Upgrades and Downgrades

HSIC has been the subject of a number of research reports. Barrington Research restated an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. Evercore ISI raised their price target on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. UBS Group lowered their target price on Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a research report on Wednesday, August 7th. Robert W. Baird reduced their price target on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 7th. Finally, StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $78.89.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.